Media Coverage (COVID-19)
COVID-19
-
- All Categories
- Brain Health
- Cancers
- Cell Dynamics
- Computational Biology
- COVID-19
- Disease
- Environment
- Experimental
- Healthspan
- Healthy Aging
- Immune System
- Infectious Disease
- Microbiome
- Nobel Prize
- Pregnancy Health
- Proteomics
- Scientific Wellness
Sort
-
- Default
- A-Z
- Z-A
- Newest
- Oldest
Second Opinion: How long haul COVID could offer clues for treating other puzzling chronic illnesses
In this guest column, Dr. Lee Hood details the ISB-led clinical study launched in March 2020 aimed at understanding learning to manage long COVID.
Inside the intense world of COVID-19 science, and unexpected findings from Seattle researchers
ISB President Dr. Jim Heath spoke with Geekwire reporter Lisa Stiffler about his quick pivot to study the biological secrets of COVID-19 shortly after the novel coronavirus became a global health threat.
Shift in immune response seen as COVID-19 progresses from mild to moderate
In this news roundup, Reuters highlights research led by ISB President Dr. Jim Heath showing how the immune response to COVID-19 shifts dramatically as patients transition from mild to moderate illness. The work was published in the journal Cell.
Nobel Laureate Dr. Mary Brunkow speaks at a press conference held at ISB on October 7, 2025. (Photo by Alex Garland for ISB)
ISB’s 2025 Nobel Prize Coverage
ISB’s Dr. Mary Brunkow received the 2025 Nobel Prize in Physiology or Medicine for transformative discoveries in immune tolerance.
Visit our Nobel Prize hub page for stories, photos, reactions celebrating this historic achievement, and more.